Blocking NMDA receptor at rest: a possible alleviation of depression
- PMID: 21804573
- PMCID: PMC4003295
- DOI: 10.1038/aps.2011.113
Blocking NMDA receptor at rest: a possible alleviation of depression
Similar articles
-
Ketamine and the potential role for rapid-acting antidepressant medications.Swiss Med Wkly. 2007 Apr 21;137(15-16):215-6. doi: 10.4414/smw.2007.11932. Swiss Med Wkly. 2007. PMID: 17525875 No abstract available.
-
N-methyl-D-aspartate glutamate receptor antagonists and the promise of rapid-acting antidepressants.Arch Gen Psychiatry. 2010 Nov;67(11):1110-1. doi: 10.1001/archgenpsychiatry.2010.138. Arch Gen Psychiatry. 2010. PMID: 21041611 No abstract available.
-
Comparative Effects of LY3020371, a Potent and Selective Metabotropic Glutamate (mGlu) 2/3 Receptor Antagonist, and Ketamine, a Noncompetitive N-Methyl-d-Aspartate Receptor Antagonist in Rodents: Evidence Supporting the Use of mGlu2/3 Antagonists, for the Treatment of Depression.J Pharmacol Exp Ther. 2017 Apr;361(1):68-86. doi: 10.1124/jpet.116.238121. Epub 2017 Jan 30. J Pharmacol Exp Ther. 2017. PMID: 28138040
-
Ketamine and phencyclidine: the good, the bad and the unexpected.Br J Pharmacol. 2015 Sep;172(17):4254-76. doi: 10.1111/bph.13222. Epub 2015 Jul 28. Br J Pharmacol. 2015. PMID: 26075331 Free PMC article. Review.
-
Ketamine for Major Depressive Disorder.Curr Top Behav Neurosci. 2024;66:131-147. doi: 10.1007/7854_2023_453. Curr Top Behav Neurosci. 2024. PMID: 37922100 Review.
Cited by
-
Polygalasaponin F induces long-term potentiation in adult rat hippocampus via NMDA receptor activation.Acta Pharmacol Sin. 2012 Apr;33(4):431-7. doi: 10.1038/aps.2011.199. Epub 2012 Jan 30. Acta Pharmacol Sin. 2012. PMID: 22286914 Free PMC article.
References
-
- Frances A.Diagnostic and Statistical Manual of Mental Disorders4th ed. Washington, DC: American psychiatric press; 2000. p354–6.
-
- Neumeister A, Nugent AC, Waldeck T, Geraci M, Schwarz M, Bonne O, et al. Neural and behavioral responses to tryptophan depletion in unmedicated patients with remitted major depressive disorder and controls. Arch Gen Psychiat. 2004;61:765–73. - PubMed
-
- Berton O, Nestler EJ. New approaches to antidepressant drug discovery: beyond monoamines. Nat Rev Neurosci. 2006;7:137–51. - PubMed
-
- Berman RM, Cappiello A, Anand A, Oren DA, Heninger GR, Charney DS, et al. Antidepressant effects of ketamine in depressed patients. Biol Psychiatry. 2000;47:351–4. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical